Rishi Gupta

Insider Reports History

Location
New York, NY
Signature
/s/ Ben Hohl, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rishi Gupta:

Company Role Class Num Shares Value Price $ Report Date Ownership
Verona Pharma plc Director Ordinary Shares 3,777,778 $75,555,560 $20.00 15 May 2023 Indirect
Turnstone Biologics Corp. Director Common Stock 0 $0 $0.3012 08 Aug 2025 Indirect
Enliven Therapeutics, Inc. Director Stock Option (right to buy) 1,580 12 Feb 2026 Direct

Insider Reports Filed by Rishi Gupta

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ELVN Enliven Therapeutics, Inc. 12 Feb 2026 2 $0 4 Director 17 Feb 2026, 19:59
TSBX Turnstone Biologics Corp. 08 Aug 2025 1 $0 4 Director 08 Aug 2025, 16:05
ELVN Enliven Therapeutics, Inc. 06 Feb 2025 1 $0 4 Director, 10%+ Owner 10 Feb 2025, 17:36
TSBX Turnstone Biologics Corp. 03 Jun 2024 1 $0 4 Director, 10%+ Owner 02 Jul 2024, 16:45
ELVN Enliven Therapeutics, Inc. 16 May 2024 2 -$22,877,262 4 Director, 10%+ Owner 20 May 2024, 17:03
ELVN Enliven Therapeutics, Inc. 13 Feb 2024 1 $0 4/A Director, 10%+ Owner 20 Feb 2024, 19:30
ELVN Enliven Therapeutics, Inc. 13 Feb 2024 1 $0 4 Director, 10%+ Owner 15 Feb 2024, 20:50
TSBX Turnstone Biologics Corp. 16 Oct 2023 1 $0 4 Director, 10%+ Owner 17 Oct 2023, 18:40
TSBX Turnstone Biologics Corp. 20 Jul 2023 6 +$4,999,992 4 Director, 10%+ Owner 24 Jul 2023, 16:40
TSBX Turnstone Biologics Corp. 20 Jul 2023 0 $0 3 Director, 10%+ Owner 20 Jul 2023, 21:51
ELVN Enliven Therapeutics, Inc. 17 May 2023 2 +$9,095 4 Director, 10%+ Owner 19 May 2023, 16:12
VRNA Verona Pharma plc 11 May 2023 4 -$9,938,132 4 Director 15 May 2023, 18:06
VRNA Verona Pharma plc 28 Apr 2023 1 $0 4 Director 28 Apr 2023, 16:20
ELVN Enliven Therapeutics, Inc. 23 Feb 2023 1 $0 4 Director, 10%+ Owner 06 Apr 2023, 20:18
ELVN Enliven Therapeutics, Inc. 23 Feb 2023 2 $0 4 Director, 10%+ Owner 27 Feb 2023, 20:53
ELVN Enliven Therapeutics, Inc. 23 Feb 2023 0 $0 3 Director, 10%+ Owner 27 Feb 2023, 20:48
VRNA Verona Pharma plc 22 Dec 2022 5 -$136,000,855 4 Director 27 Dec 2022, 16:32
VRNA Verona Pharma plc 28 Apr 2022 1 $0 4 Director 29 Apr 2022, 16:45
VRNA Verona Pharma plc 09 Aug 2021 1 $0 4 Director 10 Aug 2021, 16:46